Sandip Ganguly

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

Antonio Passaro, Jing Wang, Yan Wang et al. · Annals of Oncology · 2023 · 347 citations · Full text

Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study

Bruno Sangro, Masatoshi Kudo, Joseph P. Erinjeri et al. · The Lancet · 2025 · 151 citations · Full text

Hepatology, Transarterial Chemoembolisation, Medicine +8

Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results From the CANOPY-1 Trial

Daniel S.W. Tan, Enriqueta Felip, Gilberto de Castro et al. · Journal of Clinical Oncology · 2023 · 62 citations

Perspective of Oncology Patients During COVID-19 Pandemic: A Prospective Observational Study From India

Joydeep Ghosh, Sandip Ganguly, Debapriya Mondal et al. · JCO Global Oncology · 2020 · 53 citations · Full text

Real world experience of treatment and outcome in ALK-rearranged metastatic nonsmall cell lung cancer: A multicenter study from India

Amol Patel, Ullas Batra, Kuruswamy Thurai Prasad et al. · Current Problems in Cancer · 2020 · 22 citations

Medicine, Cancer Management, Bronchial Neoplasm +7